The'war against cancer'is studded with lost immunologic battles [1, 2]. The fancy strategies and clear evidence provided by experimental models have bitten the dust because they have proved inapplicable or worthless in clinical practice. The causes of this immunologic wasteland have been widely debated. Accusations and defences have been the subject of several papers [1-4]. New concepts and new technologies, however, are again opening up original perspectives, and imaginative campaign plans are still being proposed.
Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results
CAVALLO GP;GIOVARELLI M;
1988-01-01
Abstract
The'war against cancer'is studded with lost immunologic battles [1, 2]. The fancy strategies and clear evidence provided by experimental models have bitten the dust because they have proved inapplicable or worthless in clinical practice. The causes of this immunologic wasteland have been widely debated. Accusations and defences have been the subject of several papers [1-4]. New concepts and new technologies, however, are again opening up original perspectives, and imaginative campaign plans are still being proposed.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
